Aflac (AFL) Set to Announce Earnings on Wednesday

Aflac (NYSE:AFL) will release its earnings data after the market closes on Wednesday, May 1st. Analysts expect Aflac to post earnings of $1.58 per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

Aflac (NYSE:AFL) last issued its earnings results on Thursday, February 1st. The financial services provider reported $1.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.47 by ($0.22). The business had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $4.44 billion. Aflac had a net margin of 24.92% and a return on equity of 17.59%. During the same period last year, the business posted $1.29 EPS. On average, analysts expect Aflac to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Aflac Stock Performance

Shares of AFL stock opened at $84.54 on Tuesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.06 and a current ratio of 0.06. The company has a market capitalization of $48.64 billion, a P/E ratio of 10.91, a price-to-earnings-growth ratio of 2.29 and a beta of 0.91. The company’s 50 day moving average price is $82.79 and its two-hundred day moving average price is $81.82. Aflac has a 52 week low of $64.10 and a 52 week high of $86.26.

Analyst Upgrades and Downgrades

AFL has been the topic of several research analyst reports. Wells Fargo & Company dropped their target price on shares of Aflac from $83.00 to $81.00 and set an “equal weight” rating on the stock in a report on Thursday, April 11th. UBS Group lifted their price objective on shares of Aflac from $80.00 to $84.00 and gave the company a “neutral” rating in a report on Wednesday, January 10th. The Goldman Sachs Group lifted their price objective on shares of Aflac from $61.00 to $75.00 and gave the company a “sell” rating in a report on Tuesday, January 9th. Piper Sandler lifted their price objective on shares of Aflac from $90.00 to $95.00 and gave the company an “overweight” rating in a report on Friday, April 5th. Finally, Raymond James lifted their price objective on shares of Aflac from $83.00 to $88.00 and gave the company an “outperform” rating in a report on Friday, February 2nd. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $82.15.

Insiders Place Their Bets

In other Aflac news, SVP Albert Riggieri sold 8,000 shares of Aflac stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $83.34, for a total transaction of $666,720.00. Following the completion of the transaction, the senior vice president now directly owns 32,825 shares of the company’s stock, valued at $2,735,635.50. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Aflac news, SVP Albert Riggieri sold 8,000 shares of Aflac stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $83.34, for a total transaction of $666,720.00. Following the completion of the transaction, the senior vice president now directly owns 32,825 shares of the company’s stock, valued at $2,735,635.50. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Thomas J. Kenny sold 5,000 shares of the business’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $84.62, for a total transaction of $423,100.00. Following the completion of the sale, the director now directly owns 17,920 shares of the company’s stock, valued at approximately $1,516,390.40. The disclosure for this sale can be found here. Insiders sold a total of 46,493 shares of company stock valued at $3,765,706 over the last ninety days. 0.90% of the stock is currently owned by company insiders.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.